Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Carvedilol approved by FDA for CHF

May 30, 1997

New agents for atherosclerosis from Bayer

May 30, 1997

Yamanouchi discloses Na+/H+ exchange inhibitors

May 30, 1997

Preliminary results from phase I trial of Nortran's RSD-921 reported

May 30, 1997

Use of labetalol in renal transplant patients discouraged

May 28, 1997

Clevidipine for controlling hypertension after CABG

May 27, 1997

ET antagonists disclosed by Merck KGaA

May 27, 1997

ETA antagonist effective against neointima formation in rabbit model

May 26, 1997

Y-26763 protects against ischemia/reperfusion injury in dog model

May 26, 1997

Pfizer sponsors large cardiovascular trial in U.K. and Scandinavia

May 26, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...